Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05440318 · ClinicalTrials.gov registry record
Use of Wearable Digital Sensors After mRNA Vaccination in Adults
A clinical trial, sponsored by ModernaTX.
- Completed
- Registry status
- 62
- Enrollment target
NCT05440318: Completed study, sponsored by ModernaTX.
NCT05440318 is a clinical trial that has completed, run by ModernaTX. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05440318 has completed, sponsored by ModernaTX.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the physiological and behavioral impact of the immune response to vaccines after receipt of investigational or approved messenger ribonucleic acid (mRNA) vaccines using wearable medical sensors, with the potential of establishing a digital biomarker of vaccine response due to stimulation of the immune system.
Interventions
- DEVICE Wireless wearable digital devices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2022-06-16 |
| Est. Completion | 2023-02-07 |
What the finished NCT05440318 record still lists
NCT05440318 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Wireless wearable digital devices is the first listed.
NCT05440318 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05440318 about?
NCT05440318 is a clinical study titled "Use of Wearable Digital Sensors After mRNA Vaccination in Adults". The purpose of this study is to explore the physiological and behavioral impact of the immune response to vaccines after receipt of investigational or approved messenger ribonucleic acid (mRNA) vaccines using wearable medical sensors, with the potential of establishing a digital biomarker of vaccine...
What is the current status of trial NCT05440318?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2022-06-16. Estimated completion is 2023-02-07.
What interventions are being tested in trial NCT05440318?
The interventions under investigation include: Wireless wearable digital devices (DEVICE).
Who is sponsoring clinical trial NCT05440318?
This trial is sponsored by ModernaTX, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI